Novo Nordisk
NVO
NVO
931 hedge funds and large institutions have $16.3B invested in Novo Nordisk in 2022 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 323 increasing their positions, 311 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
931
Holders Change
+31
Holders Change %
+3.44%
% of All Funds
15.74%
Holding in Top 10
39
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+69.57%
% of All Funds
0.66%
New
91
Increased
323
Reduced
311
Closed
51
Calls
$140M
Puts
$124M
Net Calls
+$16.1M
Net Calls Change
-$28.9M
Top Buyers
| 1 |
Jennison Associates
New York
|
$1.17B |
| 2 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
$462M |
| 3 |
Morgan Stanley
New York
|
$408M |
| 4 |
Millennium Management
New York
|
$142M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
$424M |
Top Sellers
| 1 |
Fisher Asset Management
Camas,
Washington
|
$1.6B |
| 2 |
BlackRock
New York
|
$390M |
| 3 |
Renaissance Technologies
New York
|
$1.95B |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
$592M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$2.93M |
